Condition: General Information


Trajectory modeling of cannabis use over 30 years identifies five unique longitudinal patterns

Abstract Cannabis is the most prevalently used psychoactive substance in the United States. Cannabis has conflicting federal and state legal status in the US, however medical and recreational cannabis use…

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing

Abstract Objective: Evidence is accumulating that components of the Cannabis sativa plant may have therapeutic potential in treating psychiatric disorders. Medicinal cannabis (MC) products are legally available for prescription in Australia, primarily through…

Quantification of Cannabis in Infused Consumer Products and Their Residues on SkinClick to copy article link

Please use this link to access this publication. Abstract Cannabis consumer products are a $4.6 billion industry in the U.S. that is projected to exceed $14 billion by 2025. Despite an…

Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017

Abstract Objective Forthcoming legislative changes will legalize and make cannabis widely available in Canada. We conducted an analysis of Ontario’s birth registry to determine recent trends and correlates of cannabis…

The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review

Abstract Introduction: There is growing recognition of the potential of cannabis to treat various medical conditions and symptoms, such as chronic pain, spasticity, and epilepsy. However, one of the biggest challenges…

Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey

Please use this link to access this publication. ABSTRACT Many cannabis users report therapeutic benefits from cannabis consumption, even when not recommended by a physician. To date, few data on…

A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids

Abstract Background The Veterans Health Administration tracks urine drug tests (UDTs) among patients on long-term opioid therapy (LTOT) and recommends discussing the health effects of cannabis use. Objective To determine…

Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study

Please use this link to access this publication. Abstract Background and Objectives Limited evidence guides the efficacy and safety of cannabis for therapeutic purposes (CTP). Healthcare providers lack requisite knowledge…

Limited psychological and social effects of lifetime cannabis use frequency: Evidence from a 30-year community study of 4,078 twins

Please use this link to access this publication. Abstract Background: Cannabis use is associated with outcomes like income, legal problems, and psychopathology. This finding rests largely on correlational research designs,…

Use of cannabis for mental health in the Canadian territories: a cross-sectional study

Please use this link to access this publication. Abstract Background Population prevalence and patterns of cannabis use for mental health (CUMH) are underexplored. This is important to understand in the…